Tuesday - August 11, 2026
USPTO Reinstates Double Patenting Rejections In Ex Parte Baurin: What Life Sciences Innovators Need to Know
August 10, 2026
BOSTON, Massachusetts, Aug. 10 [Category: BizLaw/Legal] -- Foley Hoag, a law firm, posted the following news:

* * *

USPTO Reinstates Double Patenting Rejections In Ex Parte Baurin: What Life Sciences Innovators Need to Know

*

On August 6, 2026, the USPTO Appeals Review Panel (ARP) reinstated nonstatutory double patenting (NSDP) rejections against Sanofi's application for antibody-like binding proteins. This precedential decision has signif . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products